Rechallenge

Clinical trials for Rechallenge explained in plain language.

Never miss a new study

Get alerted when new Rechallenge trials appear

Sign up with your email to follow new studies for Rechallenge, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Second chance: can a different immunotherapy drug be safely retried after lung inflammation?

Disease control Recruiting now

This study looks at whether people with lung cancer who developed lung inflammation (pneumonitis) from immunotherapy can safely restart treatment with a different type of immunotherapy drug. Researchers will compare outcomes in patients who restart with a PD-L1 inhibitor, those w…

Matched conditions: RECHALLENGE

Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

Rechallenge

Get alerted when new Rechallenge trials appear

Second chance: can a different immunotherapy drug be safely retried after lung inflammation?